Actavis Pharma develops, manufactures and markets generics, branded generics, legacy brands and Over-the-Counter (OTC) products in more than 60 countries around the world.

The third-largest generic pharmaceutical company in the United States with approximately 10% market share, Actavis Pharma is also in the top 3 in 12 global markets, the top 5 in 16 global markets and in the top 10 in 33 global markets.